000 | 02081cam a22003737a 4500 | ||
---|---|---|---|
001 | 002023 | ||
005 | 20220906184653.0 | ||
008 | 030515s2003 sz a b i000 0 eng d | ||
010 | _a 2003362254 | ||
020 | _a9241545992 | ||
035 | _a(OCoLC)ocm52253251 | ||
040 |
_aPIT _cPIT _dVAM _dDLC |
||
042 | _alccopycat | ||
050 | 0 | 0 |
_aRA644.5 _b.A34 2003 |
060 | _aW 85 | ||
082 | 0 | 0 |
_a362.16 _222 |
245 | 0 | 0 |
_aAdherence to long-term therapies : _bevidence for action / _c[edited by Eduardo Sabaté]. |
260 |
_aGeneva : _bWorld Health Organization, _c2003. |
||
300 |
_axv, 198 p. : _bcol. ill. ; _c26 cm. |
||
504 | _aIncludes bibliographical references. | ||
505 | 0 | _aCh. I. Defining adherence -- Ch. II. The magnitude of the problem of poor adherence -- Ch. III. How does poor adherence affect policy makers and health managers? -- Ch. IV. Lessons learned -- Ch. V. Towards the solution -- Ch. VI. How can improved adherence be translated into health and economics benefits? -- Ch. VII. Asthma -- Ch. VIII. Cancer (palliative care) -- Ch. IX. Depression -- Ch. X. Diabetes -- Ch. XI. Epilepsy -- Ch. XII. HIV/AIDS -- Ch. XIII. Hypertension -- Ch. XIV. Tobacco smoking cessation -- Ch. XV. Tuberculosis -- Annex I. Behavioural mechanisms explaining adherence -- Annex II. Statements by stakeholders -- Annex III. Table of reported factors by condition and dimension -- Annex IV. Table of reported interventions by condition and dimension -- Annex V. Global adherence interdisciplinary network (GAIN). | |
650 | 0 |
_aChronic diseases _xTreatment. _9109 |
|
650 | 0 |
_aPatient compliance. _9110 |
|
650 | 0 |
_aMedical policy. _9111 |
|
650 | 1 | 2 |
_aChronic Disease _xtherapy. _9112 |
650 | 2 | 2 |
_aHealth Policy. _9113 |
650 | 2 | 2 |
_aPatient Compliance. _9114 |
700 | 1 |
_aSabaté, Eduardo. _9115 |
|
710 | 2 |
_aWorld Health Organization. _9116 |
|
856 |
_uhttp://nhrc.org.np/contact _yVisit NHRC Library |
||
906 |
_a7 _bcbc _ccopycat _d3 _encip _f20 _gy-gencatlg |
||
942 |
_2NLM _cBK |
||
999 |
_c2373 _d2373 |